Company Filing History:
2 out of 1,647 
5 out of 832,891 Years Active: 1984-1985
Title: Innovations of Wan S Kim in Glycosylated Insulins
Introduction
Wan S Kim is an accomplished inventor based in Salt Lake City, UT (US). He holds a total of 7 patents that focus on advancements in glycosylated insulins. His work has significant implications for diabetes treatment and management.
Latest Patents
Kim's latest patents include the synthesis of amido-phenyl-.alpha.-D-glucopyranoside derivatives. These derivatives involve synthesized succinyl and glutaryl glucosamines, which are reacted with insulin to form glycosylated insulins. The resulting glycosylated insulins contain from 1 to 3 glycosyl groups per insulin molecule. Notably, these novel glycosylated insulins resist aggregation and demonstrate significant activity in lowering blood sugar levels.
Career Highlights
Throughout his career, Wan S Kim has made substantial contributions to the field of biochemistry and pharmaceuticals. His innovative approaches to insulin modification have opened new avenues for diabetes treatment. His work is recognized for its potential to improve patient outcomes.
Collaborations
Kim has collaborated with notable individuals in his field, including Seo Y Jeong and James C McRea. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Wan S Kim's contributions to the development of glycosylated insulins represent a significant advancement in diabetes management. His innovative work continues to influence the field and offers hope for improved treatments.